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Ingredient  Volume TCM+ (Proteorhodopsin) DNA  5µl Forward Primer 5’ATGCCATAGCATTTTTATCC 3’  1µl Reverse Primer 5’ AACACCCCATGGATCACTAGCATCAAGGTCACCACCACCTGC’3  1µl AmpliTaq (Promega)  25µl H2O (Sterile)  18µl   Total: 50µl  
The PCR Program used to amplify proteorhodopsin N‐terminal region was: 




THE PLASMID RESTRICTION ENZYME DIGEST   A restriction enzyme, or endonuclease, is one that cleaves DNA based on short, specific, double‐stranded DNA sequence for a specific site, known as a recognition site. This occurs in‐between the ends of the DNA sequence, hence “endo‐.” (Note: exonucleases are enzymes that chew DNA from the ends). The recognition sites tend to be palindromic, although not always the case. Restriction digests can be prevented through methylation (Arber et al., 1969).     The restriction enzyme used in this lab is NcoI. The site that NcoI recognize and cuts, and the result of this reaction, are shown below (Yuan, 1981; Bickler 1993):          (Note: “…” represents a continuation of nucleotides)   In this project, the constituents for the PCR product digest with NcoI used was: 




NcoI (Promega)  1.2µl   Total: 34.7µl   The PCR Product with NcoI digest was incubated at 37°C for 1.5 hours. The constituents for the Bovine Rhodopsin digest with NcoI used was: 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 Reaction 2  Reaction3 







































(primer 1)5’ATGCCATAGCATTTTTATCC 3’ 
...CACTTTGCTATGCCATAGCATTTTTATCCATAAGATTAGCGGATCCTACCTGACGCTTTTTATCGCAACTCTCTACTGTT 3’ 
...GTGAAACGATACGGTATCGTAAAAATAGGTATTCTAATCGCCTAGGATGGACTGCGAAAAATAGCGTTGAGAGATGACAA 5’ 
                                                                  [Nco1] 
5’ TCTCCATACCGTTTTTTGGGCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACATA CCATGG AATTATTACTGA 3’ 
3’ AGAGGTATGGCAAAAAACCCGATCTTTATTAAAACAAATTGAAATTCTTCTCTATATGTCAT GGTACC TTAATAATGACT 5’ 
  
5’ TATTAGGTAGTGTTATTGCACTTCCTACTTTGCTGCAGGTGGTGGTGACCTTGATGCTAGTGATTACACTGGTGTT 3’ 
3’ ATAATCCATCACAATAACGTGAAGGATGAAACGACGTCCACCACCACTGGAACTACGATCACTAATGTGACCACAA  5’ 
                       (primer 2)   3’CGTCCACCACCACTGGAACTACGATCACTAGGTACCCCACAA 5’    

















5’ ATGCCATAGCATTTTTATCCATAAGATTAGCGGATCCTACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCC 3’ 
3’ TACGGTATCGTAAAAATAGGTATTCTAATCGCCTAGGATGGACTGCGAAAAATAGCGTTGAGAGATGACAAAGAGG 5’ 
                                                             [Nco1] 
5’ ATACCGTTTTTTGGGCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACATA CCATGG AATTATTACTG 3’ 
3’ TATGGCAAAAAACCCGATCTTTATTAAAACAAATTGAAATTCTTCCTCTATATGTAT GGTACC TTAATAATGAC 5’ 
                                                                     [Nco1] 
5’ ATATTAGGTAGTGTTATTGCACTTCCTACTTTGCTGCTGGTGGTGGTGACCTTGATGCTAGTGAT CCATGG GGTGTT 3’ 
3’ TATAATCCATCACAATAACGTGAAGGATGAAACGACGTCCACCACCACTGGAACTACGATCACTA GGTACC CCACAA 5’ 


























CAPSTONE SUMMARY   Bovine (cow) rhodopsin is a 7‐transmembrane (7TM), light‐absorbing, protein located in the eye, particularly the rod cells. It is activated by the photoisomerization of retinal, a Vitamin A derivative. This light‐triggered reaction activates the G‐Protein Coupled Receptor (GPCR), resulting in a signaling cascade within the cell, and usually a physiological response.   When previously cloned in an E. coli expression vector in the Braiman Lab, bovine rhodopsin expression was not robust, possibly due to E. coli’s lack of recognition of the foreign N‐terminus portion of the protein, which may be a prerequisite for proper folding and insertion into the membrane.     Our proposed solution is to create a chimera protein, replacing the N‐terminal leader sequence of bovine rhodopsin with proteorhodopsin’s N‐terminal leader sequence in order to successfully express this chimera in E. coli using the pBAD‐Topo® plasmid.    Proteorhodopsin (pR), a protein found in marine bacterioplankton, with analogous photochemical activity to bovine rhodopsin, was chosen to serve as a candidate for creating this chimera due to its robust, successful protein expression, giving around 10mg/L of culture, expressed in the same plasmid and bacterial system.    While our focus is on making a protein chimera, we worked with the DNA that encodes for the proteins; therefore, we had to make a 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plasmid DNA chimera, and with a restriction enzyme and PCR, the tools were available to do this.     First and foremost, LB media had to be made in order to grow out bacterial cultures, bovine rhodopsin and proteorhodopsin. After incubation of the bacterial cultures, genomic plasmid DNA has to be separately isolated from both cultures.   In order to obtain the N terminus leading sequence of proteorhodopsin, we had to use the polymerase chain reaction (PCR), which exploits the process of DNA replication to yield a large portion of the desired DNA. The primers that were used designated which area we wanted to amplify, which the N terminus leading sequence of proteorhodopsin.     The proteorhodopsin PCR product was then run on a gel to confirm that it worked. It was later digested with NcoI, an endonuclease, for the preparation of creating the plasmid DNA chimera by generating the “sticky ends” needed.   Working with bovine rhodopsin was the next step. The goal was to remove the N terminus leader sequence of this in order that it could be replaced by proteorhodopsin’s. We used NcoI to remove the this part of DNA, which left bovine rhodopsin with two of the same “sticky ends” as proteorhodopsin’s NcoI digested PCR product. This was no coincidence as this served as the pasting site of the vector, bovine rhodopsin, with the insert, proteorhodopsin’s PCR product. 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 However, the NcoI digested bovine rhodopsin had to undergo an alkaline phosphatase reaction to prevent self re‐annealing. Previous attempts of creating a chimera were not successful, so we hypothesized that this would give us a better chance at yielding a product. The way in which the alkaline phosphatase reaction works is opposite of that of a kinase; it removes the phosphate groups through hydrolysis. Following this step, ethanol precipitation was performed to remove unwanted salts.   Finally, the ligation was done on the proteorhodopsin and bovine rhodopsin processed DNA fragments in order to paste the DNA, finalization the creation of the chimera DNA plasmid. After this step was complete, the plasmid was then transformed into bacteria to test if the ligation worked by protein expression, as well as use of the antibiotic, ampicillin.    Topo® plasmid was used to essentially carry bovine rhodopsin. What is useful about this is that it encodes for an antibiotic resistance against ampicillin, which does not permit ampicillin, when treated, to kill off the bacteria. Therefore, if bacterial colonies still proliferate after this antibiotic treatment, it suggests that the plasmid conferring the antibiotic resistance is present, and that the plasmid was successfully transformed into bacteria.   Through gel electrophoresis, I was able to confirm that the DNA from both bacterial cultures, bovine rhodopsin and proteorhodopsin, were isolate. Also, I was able to confirm that the NcoI digest of bovine 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rhodopsin and the PCR of proteorhodopsin N terminus leading sequence both succeeded.   Confirming the creation of the chimera is still undergoing in the Braiman Lab. Characterization of protein expression must be done after confirmation of the chimera’s creation has been made. Following this, purification of the protein, such as citrate purification, which is being perfect in the Braiman Lab with patent pending, can be used in hopes of creating a pure enough protein to allow its crystallization.          
      
  
